ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.11 Cr | ₹-8.27 Cr | ₹-6.36 Cr | ₹-1.59 Cr | ₹-1.71 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹0.11 Cr |
| Mar2024 | ₹-8.27 Cr |
| Mar2023 | ₹-6.36 Cr |
| Mar2022 | ₹-1.59 Cr |
| Mar2021 | ₹-1.71 Cr |
How is Cash Flow from Financing Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.11 Cr | Positive | |
| Mar2024 | ₹-8.27 Cr | Negative | |
| Mar2023 | ₹-6.36 Cr | Negative | |
| Mar2022 | ₹-1.59 Cr | Negative | |
| Mar2021 | ₹-1.71 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹428.7 Cr | -1.8% | -8.9% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,220.0 Cr | 1.2% | 2.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,486.0 Cr | 0.9% | -2.5% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,963.0 Cr | 0.5% | -1.5% | 12.3% | Stock Analytics | |
| CIPLA | ₹121,751.0 Cr | 1.1% | -1.6% | 4.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,866.0 Cr | 2.7% | 2.9% | 3.3% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -1.8% |
-8.9% |
-49.1% |
| SENSEX | 0.1% |
0.9% |
4.5% |
You may also like the below Video Courses